Here are the 10-Q quarterly reports from Iris Acquisition Corp II (IRAB) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow IRAB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IRAB filings page.
Iris Acquisition Corp II (IRAB), a blank-check company, reported net income of $1,430,836 for the three months ended September 30, 2026, as $1,607,506 of Trust Account interest exceeded $175,559 of general and administrative costs and $1,111 of interest expense. It had no operating revenue and had not selected a business-combination target. The Trust Account held $172,550,456; cash outside it was $574,063, and working capital was $233,855.
Management said it lacks liquidity to sustain operations for a reasonable period, which it considers at least one year from issuance, raising substantial doubt about the company’s ability to continue as a going concern. Its 24-month period to complete a business combination runs from the February 4, 2026 IPO closing. On October 20, 2026, it entered a note with Harraden Circle Investors LP, Harraden Circle Concentrated LP and Harraden Circle Special Opportunities LP; the full $250,000 was drawn by the financial-statement issuance date. A completed combination triggers an Additional Return of 150% of principal on or before December 31, 2027, or 250% afterward; if the company liquidates or its combination deadline expires without a deal, principal is payable only from funds outside the Trust Account.
Iris Acquisition Corp, a Cayman Islands SPAC, completed its February 2026 IPO of 16,850,000 units at $10.00 per unit and 438,000 private placement units, placing $168,500,000 into a Trust Account. As of June 30, 2026, total assets were $171,755,229, including $170,942,950 of cash in the Trust Account and $699,573 of cash outside the Trust. Class A ordinary shares subject to possible redemption totaled $170,942,950 (16,850,000 shares).
For the three and six months ended June 30, 2026, the company reported net income of $1,263,575 and $2,037,510, driven almost entirely by interest income of $1,523,388 and $2,442,950 on Trust Account funds, partially offset by general and administrative expenses of $259,423 and $403,535. Iris disclosed a shareholders’ deficit of $6,681,507 and a deferred underwriting fee payable of $7,115,000. Management states there is substantial doubt about the company’s ability to continue as a going concern due to limited liquidity and the requirement to complete a business combination within 24 months of the February 4, 2026 IPO closing (the Completion Window), after which the company must liquidate if no deal is completed.
Iris Acquisition Corp II, a Cayman Islands SPAC, reported net income of $773,935 for the quarter ended March 31, 2026, driven mainly by $919,562 of interest on its IPO trust assets and modest operating expenses of $144,112.
The company completed its IPO on February 4, 2026, selling 16,850,000 units at $10.00 each and placing $168,500,000 into a Trust Account, which grew to $169,419,562 with interest. Cash outside the Trust Account was $854,833, used to fund search and operating costs.
The SPAC has 24 months from the IPO closing to complete a business combination or return the trust funds to public shareholders, who may also redeem shares in connection with any approved deal. As of May 14, 2026, there were 17,288,000 Class A and 5,616,667 Class B ordinary shares outstanding.